Live Mass Tort Intelligence
FDA safety alerts, MAUDE adverse-event reports, EPA enforcement actions, federal court dockets, product recalls, and scientific literature — continuously monitored and unified into one litigation intelligence feed.
46
Torts Monitored
29
With Recent Activity
455
Activity This Week
68
Sources Tracked
Daily Intelligence Brief
April 28, 2026
Weekly Docket: Talc, Suboxone, and Depo-Provera Drive 734 Federal Filings
LexGenius tracked 734 new federal filings across 582 dockets last week, with volume concentrated in mass-tort pharmaceutical and consumer-product MDLs. The Johnson & Johnson Talcum Powder Products Liability Litigation (MDL 2738) led with 209 filings paced by Duncan Stubbs / OnderLaw LLC (149) and Napoli Shkolnik (37); the Suboxone Film Products Liability Litigation (MDL 3092) added 152 plaintiffs across two mass-joinder dockets filed by Keller Postman LLC (100 plaintiffs) and Peiffer Wolf (52); the Depo-Provera Products Liability Litigation (MDL 3140) logged 66 new suits paced by The Miller Firm LLC and Ben Martin Law Group (7 each); and the Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL 3060) added 53 cases distributed across a broad plaintiff bar.Trial Calendar Heats Up: Ozempic Motion Deadlines This Week, Uber Bellwether Verdict, Depo-Provera Hearings on Deck
The Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation (MDL 3094) hits two pivotal filing deadlines this week before Judge Karen S. Marston (E.D. Pa.): Daubert motions to exclude general-causation experts are due April 28, 2026 and summary-judgment motions are due April 30, 2026 — the most consequential paper drop of the quarter for Novo Nordisk and Eli Lilly, after Marston previously required plaintiffs to produce objective gastric-emptying studies. On April 20, a federal jury in the Uber Technologies Passenger Sexual Assault Litigation (MDL 3084) found Uber liable in the Mensing bellwether out of W.D.N.C. and awarded roughly $5,000 — damages were capped at a single 24-hour window without accounting for lasting emotional impact, a sharp contrast to the prior Dean verdict of $8.5 million; the next two consecutive bellwethers begin September 14, 2026 in N.D. Cal. before Judge Charles R. Breyer. The Depo-Provera Products Liability Litigation (MDL 3140) has general-causation Daubert hearings rescheduled to June 24–26, 2026 before Judge M. Casey Rodgers (N.D. Fla.), with the first bellwether (Toney v. Pfizer) set for December 7, 2026 and a pilot pool that also includes Blonski, Schmidt, Wilson, and Valera-Arceo.JPML Scale Snapshot and Bellwether Pipelines Across the Largest Pending MDLs
Against the JPML's most recent active-dockets baseline, last week's volume sits inside several of the largest pending MDLs. The Talcum Powder Litigation carries 67,376 pending dockets before Judge Michael A. Shipp (D.N.J.), where an April 8, 2026 status order required the parties to submit a joint update on pretrial motions and trial readiness with Carter Judkins selected as the next bellwether case. The Suboxone MDL holds 1,836 pending dockets before Judge J. Philip Calabrese (N.D. Ohio); the new CMO directs 20 of 100 cases into core discovery by June 10, 2026, with depositions running through January 15, 2027, dispositive motions due March 12, 2027, and the first trial set for March 2028. The Hair Relaxer Litigation sits at 11,371 pending dockets before Judge Mary M. Rowland (N.D. Ill.), who on April 8, 2026 selected a 10-case bellwether pool to advance into core discovery. GLP-1 RAs (MDL 3094) stands at 3,546 pending dockets, Depo-Provera (MDL 3140) at 3,490, and the Social Media Adolescent Addiction Litigation (MDL 3047) at 2,465 pending dockets before Judge Yvonne Gonzalez Rogers (N.D. Cal.) — where the second pretrial conference and MSJ motions hearing was held April 14–15, 2026 and the parallel state bellwether (K.G.M. v. Meta/YouTube) returned a $6 million plaintiff verdict in late March.Analyst Workbench
Track litigations for free — sign in to get started.
Save matters, capture notes, and monitor live signals — sign in to get started.
Featured Dockets
Medical device
MDL 2846 bellwether scheduling, Bard and Davol settlement activity, and adverse-event tracking
Medical device
MDL 3029 bellwether scheduling, Covidien motion practice, and adverse-event tracking
Medical device
Consolidation motion activity, adverse-event reports, device recall activity, and bellwether scheduling
Medical device
MDL 3081 (D. Ariz.) case management orders, bellwether selection, Becton Dickinson design-defect rulings, and catheter fracture adverse-event reports
Consumer / platform liability
Individual and class action filings against Activision, Epic, and Roblox alleging addictive game design, JPML consolidation petitions, FTC and state AG enforcement actions, and DSM gaming disorder clinical research
Negligence / survivor litigation
MDL 3171 scheduling orders, Lyft safety disclosures, and legislative responses
Institutional abuse
BSA bankruptcy trust (D. Del.) claims processing and distribution orders, state lookback window filings, local council contribution disputes, and Hartford and Century indemnity proceedings
Consumer / platform liability
MDL 3166 docket activity, JPML consolidation developments, child-safety policy, and platform design liability
Toxic exposure
Cook County and Gwinnett/Cobb County state toxic-tort verdicts and settlements, EPA fenceline monitoring rule implementation, Sterigenics and Becton Dickinson site-specific rulings, and IARC/EPA carcinogenicity updates
Institutional abuse
State civil abuse suits against LDS Church entities, clergy-penitent privilege rulings in Utah and other jurisdictions, state lookback window legislation, and church mandatory-reporting reform activity
Environmental exposure
EPA drinking-water maximum contaminant level rulemaking for 1,4-dioxane, state Superfund and CERCLA remediation orders, consumer-product contamination enforcement, and NTP carcinogenicity classification updates
Consumer tech / product liability
P.J. v. Character Technologies (N.D.N.Y. 1:25-cv-01295) and Gavalas v. Google (N.D. Cal. 5:26-cv-01849) docket activity, JPML consolidation petitions, FTC AI safety enforcement actions, and suicide-contagion and chatbot-harm clinical research
Litigation Dashboard
| Tort | Category | Trend | Activity Status | LexGenius Ranking | |
|---|---|---|---|---|---|
| Bard Hernia Mesh | Medical device | — | OPEN | 96Activity | |
| Covidien Hernia Mesh | Medical device | — | OPEN | 96Activity | |
| Spinal Stimulators | Medical device | — | EXPANDING | 96Activity | |
| PowerPort | Medical device | — | EXPANDING | 94Activity | |
| Depo-Provera | Pharmaceutical | — | EXPANDING | 92Activity | |
| Suboxone Teeth | Pharmaceutical | — | OPEN | 92Activity | |
| Ozempic Gastroparesis | Pharmaceutical | — | OPEN | 92Activity | |
| Ozempic NAION | Pharmaceutical | — | OPEN | 92Activity | |
| Zantac | Pharmaceutical | — | OPEN | 92Activity | |
| Cartiva | Medical device | — | OPEN | 92Activity | |
| Talc | Product liability | — | OPEN | 88Activity | |
| PFAS | Environmental exposure | — | OPEN | 88Activity | |
| Paragard | Medical device | — | MONITORING | 87Activity | |
| AFFF | Toxic exposure | — | OPEN | 86Activity | |
| Roundup | Product liability | — | OPEN | 84Activity | |
| Paraquat | Product liability | — | OPEN | 84Activity | |
| Tylenol | Pharmaceutical | — | OPEN | 84Activity | |
| Dupixent CTCL | Pharmaceutical | — | EXPANDING | 84Activity | |
| Social Media | Platform liability | — | OPEN | 82Activity | |
| NEC Formula | Medical nutrition | — | OPEN | 80Activity | |
| ByHeart Formula | Product liability | — | EXPANDING | 80Activity | |
| Hair Relaxer | Product liability | — | OPEN | 79Activity | |
| Benzene Litigation | Toxic exposure | — | EXPANDING | 78Activity | |
| Camp Lejeune | Toxic exposure | — | OPEN | 76Activity | |
| Uber Assault | Negligence / survivor litigation | — | OPEN | 76Activity | |
| Hotel Trafficking | Survivor litigation | — | MONITORING | 70Activity | |
| Baby Food Metals | Product liability | — | OPEN | 70Activity | |
| Video Game Addiction | Consumer / platform liability | — | EXPANDING | 67Active Watch | |
| Lyft Assault | Negligence / survivor litigation | — | OPEN | 66Active Watch | |
| Boy Scouts | Institutional abuse | — | MONITORING | 62Active Watch | |
| Roblox | Consumer / platform liability | — | OPEN | 62Active Watch | |
| Discord Abuse | Consumer tech / product liability | — | EXPANDING | 62Active Watch | |
| Social Media Sextortion | Consumer / platform liability | — | EXPANDING | 62Active Watch | |
| Church Abuse | Institutional abuse | — | OPEN | 56Active Watch | |
| UPF Litigation | Product liability | — | EXPANDING | 54Active Watch | |
| EtO Sterilization | Toxic exposure | — | MONITORING | 48Moderate Activity | |
| LDS Abuse | Institutional abuse | — | MONITORING | 48Moderate Activity | |
| 1,4-Dioxane | Environmental exposure | — | MONITORING | 47Moderate Activity | |
| AI Chatbot Harm | Consumer tech / product liability | — | OPEN | 46Moderate Activity | |
| Sports Betting | Consumer / platform liability | — | EXPANDING | 44Moderate Activity | |
| Oxbryta | Pharmaceutical | — | EXPANDING | 42Moderate Activity | |
| Keytruda | Pharmaceutical | — | EXPANDING | 40Moderate Activity | |
| LDS MTC | Institutional abuse | — | EXPANDING | 38Moderate Activity | |
| CA Women's Prisons | Civil rights / institutional harm | — | MONITORING | 36Moderate Activity | |
| Assembly of God | Institutional abuse | — | MONITORING | 34Moderate Activity | |
| Royal Rangers | Institutional abuse | — | EXPANDING | 34Moderate Activity |
